Antibody response to second dose of the BNT162b2 mRNA vaccine in the first 12 weeks in South Korea: A prospective longitudinal study

OBJECTIVES: To characterise the antibody response for 12 weeks following second dose of the Pfizer/BioNTech BNT162b2 mRNA vaccine in hospital workers of a Korean general hospital. METHODS: We measured the level of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) anti-receptor binding dom...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyun Jin, Yun, Heon Jeong, Kim, Jungok, Kym, Sungmin, Choi, Qute
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694796/
https://www.ncbi.nlm.nih.gov/pubmed/34953606
http://dx.doi.org/10.1016/j.vaccine.2021.12.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694796/
https://www.ncbi.nlm.nih.gov/pubmed/34953606
http://dx.doi.org/10.1016/j.vaccine.2021.12.012

Ejemplares similares